Insider · CIK 0001681047
Christofer Christoforou
cooofficer
Files at NVRO (NEVRO CORP). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | NVRO NEVRO CORP | DDisposition to issuer Common Stock | -363,765 | - | - | 0 | Apr 3, 2025 |
| Mar 20, 2025 | NVRO NEVRO CORP | AGrant or award Common Stock | +852 | $0.00 | $0 | 124,046 | Mar 24, 2025 |
| Mar 20, 2025 | NVRO NEVRO CORP | FTax withholding Common Stock | -458 | $5.78 | $2,647 | 123,588 | Mar 24, 2025 |
| Mar 7, 2025 | NVRO NEVRO CORP | FTax withholding Common Stock | -1,328 | $5.77 | $7,663 | 134,527 | Mar 11, 2025 |
| Mar 7, 2025 | NVRO NEVRO CORP | FTax withholding Common Stock | -11,333 | $5.77 | $65k | 123,194 | Mar 11, 2025 |
| Feb 28, 2025 | NVRO NEVRO CORP | AGrant or award Common Stock | +530 | $0.00 | $0 | 137,610 | Mar 4, 2025 |
| Feb 28, 2025 | NVRO NEVRO CORP | FTax withholding Common Stock | -313 | $5.72 | $1,790 | 137,297 | Mar 4, 2025 |
| Feb 28, 2025 | NVRO NEVRO CORP | FTax withholding Common Stock | -642 | $5.72 | $3,672 | 136,655 | Mar 4, 2025 |
| Mar 2, 2025 | NVRO NEVRO CORP | FTax withholding Common Stock | -800 | $5.72 | $4,576 | 135,855 | Mar 4, 2025 |
| Dec 7, 2024 | NVRO NEVRO CORP | FTax withholding Common Stock | -1,319 | $4.19 | $5,527 | 137,080 | Dec 9, 2024 |
| Nov 28, 2024 | NVRO NEVRO CORP | FTax withholding Common Stock | -583 | $4.58 | $2,670 | 138,399 | Dec 2, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.